Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2024 Jun 18;26(Suppl 4):0. doi: 10.1093/neuonc/noae064.214

EPEN-12. EZHIP IMPACTS CELLULAR DIFFERENTIATION IN POSTERIOR FOSSA GROUP A EPENDYMOMA

Carola Jaunecker 1, Anne Jenseit 2, Theresa Zehetbauer 3, Natalia Stepien 4, Shanzheng Wang 5, Katharina Bruckner 6, Jens-Martin Hübner 7, Lisa Gabler 8, Alexandra Lang 9, Sibylle Madlener 10, Leah Mager 11,12, Christine Haberler 13, Walter Berger 14, Christian Dorfer 15, Mariella Filbin 16,17, Marcel Kool 18,19, Johannes Gojo 20, Daniela Lötsch-Gojo 21
PMCID: PMC11183852

Abstract

BACKGROUND

High-risk ependymomas are central nervous system tumors comprising ten molecular groups with posterior fossa group A (PFA) and supratentorial ependymoma with zinc finger translocation associated (ST-ZFTA) fusions being among the most aggressive subgroups in children. Loss of H3K27 trimethylation maintained by Enhancer of Zeste homologs Inhibitory Protein (EZHIP) overexpression in PFA or ZFTA-RELA oncofusions in ST-ZFTA ependymoma are known as important driver events. Additionally, we uncovered that high-risk ependymomas arise from undifferentiated cell populations, while more differentiated ependymal-like signatures (e.g. ciliogenic programs) are enriched in prognostically favourable subtypes.

METHODS

We investigated presence of “ependymal-like” signatures by analysing mRNA expression of selected genes (RSPH1, DNAAF1, SLC47A2, CAPS, CAPS-L) in ependymoma bulk samples (n=90). Gene expression was correlated to clinicopathological characteristics (EZHIP expression, 1q-gain/6q-loss, DNA methylation subtype). Impact on mRNA levels of ependymal-like markers was investigated upon an inducible EZHIP knockdown using lentiviral vectors in EPD210FH PFA cells.

RESULTS

Ependymal-like markers were significantly lower expressed in ST-ZFTA as compared to spinal and PFB ependymoma. In PFA ependymoma two distinct groups showing either low or high expression of these ependymal-like genes were present. In detail, “ependymal-like-high” PFA were assigned to the PFA-2 subtype which was also confirmed in an independent cohort. EZHIP was strongly negative prognostic in our cohort and the expression was distinctly induced during PFA progression accompanied by increased ependymal-like signature genes. This suggests an impact of EZHIP on cell differentiation processes particularly during PFA progression. Knock-down of EZHIP in EPD210FH PFA cells increased expression of ependymal signature genes associated with ciliogenesis. Next, we will spatially dissect the correlation between EZHIP and ependymal-like genes in primary and recurrent PFA and investigate DNA methylation, histone marks and EZHIP binding at these gene loci.

CONCLUSION

Overall, our data indicate that ependymal-like cell differentiation is deregulated by EZHIP particularly in progressive PF-A ependymoma.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES